41 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28218840	38	Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.	East China University of Science and Technology
28065501	38	Synthesis, docking, cytotoxicity, and LTA	Mansoura University
27651294	25	Thermodynamic properties of leukotriene A	Goethe-University Frankfurt
24125851	48	Novel acetamidothiazole derivatives: synthesis and in vitro anticancer evaluation.	University of Mansoura
23260350	49	Identification of benzofuran central cores for the inhibition of leukotriene A(4) hydrolase.	Janssen Research and Development
23220644	50	Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.	Peking University
23127888	56	Azabenzthiazole inhibitors of leukotriene A4 hydrolase.	Janssen Research and Development
22796349	34	Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors.	Universit£
12139459	74	Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.	Pfizer
10691697	133	Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.	Searle Research and Development
	38	Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase	TBA
	8	Probing the inhibition of leukotriene A4 hydrolase based on its aminopeptidase activity	TBA
22059882	206	5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor.	Amira Pharmaceuticals
21542630	135	Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase.	Peking University
21377770	26	Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors.	Gyeongsang National University (Gnu)
21292493	23	Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.	Merck Sharpe and Dohme
20371179	37	Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.	Decode Chemistry
19950900	18	Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.	Decode Chemistry
19618939	36	Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.	Decode Biostructures
8904845	3	Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus.	Searle Research and Development
19090779	12	Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.	Peking University
18952425	8	Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives.	Peking University
18674901	32	Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.	Santen Pharmaceutical
18590959	61	Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.	Berlex Biosciences
18586492	81	Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase.	Berlex Biosciences
12643929	18	Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase.	Pfizer
12419366	27	Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.	Pharmacia
32551007	19	Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase.	Goethe-University
31751136	6	Effect of Modifier Structure on the Activation of Leukotriene A	George Mason University
32184960	34	Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA	Goethe University Frankfurt
30846252	23	Recent developments in the synthesis and applications of phosphinic peptide analogs.	Wroclaw University of Technology
8423594	39	Development of selective tight-binding inhibitors of leukotriene A4 hydrolase.	Scripps Research Institute
29630364	63	Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.	Jadavpur University
10926521	15	Crystals of the urokinase type plasminogen activator variant beta(c)-uPAin complex with small molecule inhibitors open the way towards structure-based drug design.	Max-Planck-Institut Fuer Biochemie